Unlocking the Longevity Secrets of Man’s Best Friend
Matt Kaeberlein – Longevity Expert
Our guest today is Matt Kaeberlein, Ph.D., a globally recognized researcher and expert in the biology of aging. Dr. Kaeberlein’s research is based around the premise that understanding the molecular mechanisms of aging will lead to interventions that slow the onset and progression of age-related chronic conditions, such as cancer, diabetes, kidney disease, heart disease, Alzheimer’s and others. Dr. Kaeberlein received his Ph.D. from the Massachusetts Institute of Technology in 2002 advised by Leonard Guarente, and did his post-doctoral work with Stanley Fields in the Department of Genome Sciences at the University of Washington.
Dr. Kaeberlein’s expertise in dietary restriction, longevity genes for therapeutics, aging in dogs, and Rapamycin really shines in this conversation. We were lucky enough to really explore his background while sharing our collective love of dogs. The conversation explores many areas, including:
What is the difference between calories restriction and dietary restriction
What are the biggest challenges with the science
How Matt thinks about tailored dietary advice
Why Matt launched the Dog Aging Project
What we can learn from his research with dogs
What is Rapamycin and why he’s so interested in its effects
This conversation was incredibly illuminating and really fun. We hope you enjoy the episode and share it with your friends, family, and colleagues.
We hope you enjoy!
P.S. Don't forget to share! ↓
Just click to tweet this episode to your friends!
What is the difference between calorie restriction and dietary restriction?
Can dogs teach us about human longevity?
Dog lovers, this episode of the How to Live to 200 Podcast is for you!
